Ear Myoclonus: Evaluation and Treatment
Begin evaluation with a comprehensive otologic examination using otoscopy to observe for tympanic membrane flutter synchronized with the patient's tinnitus, and obtain a long-term acoustic tympanogram to document waveforms matching the tinnitus frequency—these findings confirm middle ear myoclonus (MEM). 1
Clinical Presentation
MEM presents as objective tinnitus with diverse characteristics including:
- Rhythmic clicking, drumming, or "stepping on snow" sounds
- Symptoms triggered by external sounds, position changes, facial/auricular touch, speaking, chewing, or blinking
- Can be unilateral (most common) or bilateral
- Tympanic membrane may flutter visibly with tinnitus frequency in some cases 2
Key diagnostic distinction: The ACR Appropriateness Criteria specifically emphasize distinguishing MEM from vascular causes of objective tinnitus through physical examination before ordering imaging 1. This prevents unnecessary radiation exposure and cost.
Diagnostic Workup
Essential Initial Tests:
- Otoscopic examination during tinnitus episodes - look for tympanic membrane flutter synchronized with symptoms
- Long-term acoustic tympanogram - documents waveforms matching tinnitus frequency (diagnostic even when tympanic membrane flutter isn't visible) 2
- Pure tone audiometry - hearing typically remains normal in MEM 2
- Stapedial reflex testing - may show abnormalities
Imaging is NOT routinely indicated
The ACR guidelines explicitly state that imaging should be reserved for cases where vascular causes cannot be excluded clinically 1. MEM is diagnosed through clinical examination and audiologic testing, not imaging.
Treatment Algorithm
Step 1: First-Line Pharmacologic Management
Start with carbamazepine as the primary medical therapy 2, 3. In a series of 54 patients:
- Complete control: 19% (10/54)
- Partial relief: 43% (23/54)
- No effect: 39% (21/54)
Alternative medications include:
Trial duration: Adequate trial of 4-8 weeks before declaring treatment failure.
Step 2: Botulinum Toxin (Emerging Option)
For patients failing oral medications, intratympanic botulinum toxin injection into the stapedius and/or tensor tympani muscles offers a minimally invasive, reversible option before definitive surgery 4, 5. This serves both diagnostic and therapeutic purposes:
- Confirms MEM diagnosis if symptoms resolve
- Provides temporary relief (3-6 months)
- Allows patient to experience symptom-free state before committing to permanent surgery
Step 3: Surgical Management
For medication-refractory cases, surgical tenotomy of middle ear muscles is highly effective 6, 2. In systematic review data:
- Success rate: 88% (7/8 patients in one series had complete resolution) 2
- Most common approach: Division of both stapedius AND tensor tympani tendons (88% of surgical cases) 6
Surgical considerations:
- Endoscopic techniques offer improved visualization and reduced invasiveness 4
- Risk of hyperacusis post-operatively
- Potential for symptom recurrence from tendon reattachment 4
- May require repeat procedures in some cases 2
Special Circumstances
Pediatric patients or those with comorbid epilepsy: Treat underlying seizure disorder first—tinnitus may resolve with antiepileptic therapy 2
Post-facial nerve surgery cases: May not require specific treatment; symptoms can be self-limited 2
Common Pitfalls to Avoid
Don't order imaging reflexively - MEM is a clinical diagnosis; imaging is only indicated when vascular causes cannot be excluded 1
Don't assume treatment failure after brief medication trial - adequate pharmacologic trials require 4-8 weeks
Don't perform isolated stapedius or tensor tympani tenotomy - dividing both tendons yields better outcomes 6
Don't overlook psychiatric comorbidity - patients with severe anxiety or depression require prompt identification and intervention, as suicide risk exists in tinnitus patients with psychiatric illness 1
The evidence base for MEM management remains limited, with most data from case series and small cohort studies 4, 6. However, the stepwise approach from conservative medical management through minimally invasive botulinum toxin to definitive surgery provides a rational framework balancing efficacy against invasiveness and reversibility.